Search results
AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
The Independent via Yahoo News· 5 days agoThe withdrawal was due to a “surplus of available updated vaccines” against new variants of the...
WHO in talks to finalize ‘pandemic treaty’ | Northwest Arkansas Democrat-Gazette
Northwest Arkansas Democrat Gazette· 1 day agoAfter the coronavirus pandemic triggered once-unthinkable lockdowns, upended economies and killed...
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 2 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 3 days agoNovavax on Friday said it has signed a multibillion-dollar deal with French drugmaker Sanofi to...
Plea in SC seeks medical panel under retired apex court judge to examine Covishield side effects
Investing.com· 2 weeks agoPlea in SC seeks medical panel under retired apex court judge to examine Covishield side effects
AstraZeneca COVID Vaccine
Anacortes American· 5 days agoFILE - Medical staff prepares an AstraZeneca coronavirus vaccine during preparations at the vaccine center in Ebersberg near Munich, ...
AstraZeneca withdraws its vaccine to protect against COVID-19 worldwide
CBC via Yahoo News· 4 days agoAstraZeneca says it is withdrawing Vaxzevria, its vaccine to protect against COVID-19, from global...
AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide
RTT News· 5 days agoThe latest move follows a notice by the European Medicines Agency that the vaccine is no longer authorised for use. Vaxzevria, a vaccine for preventing ...
What is at stake in UK local voting ahead of a looming general election
Associated Press· 2 weeks agoMillions of voters in England and Wales will cast their ballots on Thursday in an array of local...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock...
Digital Journal· 2 weeks agoI Clinical Trial of NV-387 is completed successfully and data lock is expected soon. The Phase 1 clinical trial, protocol number KM-NVCoV2-001, which received approval from the regulatory agency ...